STEMREGEN® Named to Inc. 5000 for Third Consecutive Year

STEMREGEN® Named to Inc. 5000 for Third Consecutive Year

PR Newswire

WHITEFISH, Mont., Sept. 25, 2026

Stem cell science company ranks No. 332 nationally following 1,017% three-year growth

WHITEFISH, Mont., Sept. 25, 2026 /PRNewswire/ -- STEMREGEN®, the leader in science-backed stem cell supplements supporting the body's innate repair system, has been named to the Inc. 5000 list of America's fastest-growing private companies for the third consecutive year.

STEMREGEN ranked No. 332 on the 2026 list, with three-year revenue growth of 1,017%. The company previously ranked No. 265 in 2025 and No. 1,765 in 2024, marking three consecutive years among the fastest-growing privately held companies in the United States.

The annual Inc. 5000 provides a data-driven look at the most successful companies within the economy's dynamic independent and entrepreneurial business sector. Companies are ranked according to percentage revenue growth over a three-year period, with the 2026 ranking measuring growth from 2022 through 2025.

"Being recognized on the Inc. 5000 for a third consecutive year is especially meaningful because it demonstrates sustained growth rather than a single exceptional year," said Dave Huffman, CEO. "Our growth reflects increasing awareness of the role stem cells play in the body's natural repair system and the growing demand for science-backed approaches that support healthy aging and longevity. We are incredibly proud of what our team has built and excited about where STEMREGEN is headed next."

Founded on more than two decades of research by stem cell scientist Christian Drapeau, MSc, STEMREGEN develops plant-based supplements designed to support the body's endogenous stem cell system. Its product portfolio is built around supporting key aspects of stem cell function, including the natural release of stem cells from bone marrow, their circulation through the bloodstream, and their migration into tissues.

The company's continued growth comes as interest in regenerative health, longevity, and the body's natural repair mechanisms continues to expand among consumers, health professionals, athletes, and the broader wellness community.

The 2026 Inc. 5000 companies achieved a median three-year revenue growth rate of 130%. STEMREGEN's 1,017% growth places the company well above that benchmark and among the top 350 fastest-growing private companies in the country.

Complete results of the 2026 Inc. 5000, including company profiles and an interactive database sortable by industry and location, are available at Inc.com/Inc5000.

About STEMREGEN®

STEMREGEN® develops science-backed supplements designed to support the body's innate repair system by increasing the number of circulating stem cells and supporting their natural function. Founded by stem cell scientist Christian Drapeau, MSc, STEMREGEN's formulations build on more than 20 years of research into natural compounds that support endogenous stem cell mobilization and function.

For more information, visit Stemregen.co.

Media Contact: Stephanie Marie marketing@stemregen.co

View original content to download multimedia:https://www.prnewswire.com/news-releases/stemregen-named-to-inc-5000-for-third-consecutive-year-302890705.html

SOURCE Biomics LLC, dba STEMREGEN